July 29, 2021

Clinical Evaluation: Measurable Objectives and Acceptance Criteria to Verify Device Safety and Performance

Clinical Evaluation: Measurable Objectives and Acceptance Criteria to Verify Device Safety and Performance

In this presentation we discuss strategies for the verification of device safety and performance in the clinical evaluation. Our seasoned CER medical writers are rooted in MDR-compliant practices. Likewise, this presentation will help you identify meaningful safety and performance measures for the clinical evaluation. In addition, we will define parameters to determine the acceptability of benefit-risk. Afterwards, we will have about 10-15 minutes to answer any questions you may have on this topic.

Who should watch the recording?

Those Regulatory, Quality and Clinical leaders and teams who develop, write, review or approve CERs for EU MDR submission. Anyone interested in learning more about MDR requirements for CERs is encouraged to come too. We encourage attendees from the IVD industry to attend as well, as the content is also relevant to IVDR requirements, which align closely with MDR.

Watch the recording!

Clearly Defining Measurable Safety and Performance Endpoints

All medical devices selling in Europe must have a Clinical Evaluation Report (CER). Specific and measurable safety and performance endpoints are paramount for an acceptable CER. However, many small medical device manufacturers are struggling to adequately define and subsequently document measurable safety and performance endpoints, especially in the literature review, to support an evidence-based evaluation

The newest regulations for medical devices, Medical Device Regulation (MDR) 2017/745 and MEDDEV 2.7/1 revision 4, set high standards for confirming safety and performance according to the manufacturer’s Instructions for Use. Previously, regulations under the old MDR and MEDDEV were not as demanding. Also, manufacturers are not accustomed to the current systematic process of CER evaluations. Read more on this topic in our recent blog post, here.

Want to read the highlights to verifying your device’s safety and performance? Download our white paper where we give your the best approaches to finding measurables objectives and acceptance criteria for your medical device.

Categories:
Do you like it?0
June 1, 2021

[FEATURED] Commission Calls For Notified Body Applicants As It Recognizes EU IVD Industry In Some Trouble

The European Commission is publicly recognizing the huge hurdles ahead for the IVD industry in complying with the IVD Regulation. Delaying the regulation has long been off its agenda, but it is struggling to find solutions.

Do you like it?0
May 25, 2021

[FEATURED] Open The Champagne! EU Go Ahead For Standards Needed For New Medtech Regulations

The EU has the green light to adopt and list standards that will be recognized under the MDR and IVDR. But there will be no escaping the impact of the delays, especially for the IVD sector.

Do you like it?0
May 18, 2021

[FEATURED] EU MDR Guidances: Can Stakeholders Be Punished For Not Applying Them?

Over 70 guidance documents have been drafted to support MDR implementation. But there is confusion over whether guidance is legally binding, especially where it applies to notified bodies.

Do you like it?0
May 4, 2021

[FEATURED] TEAM-NB Highlights Survey Figures Suggesting Massive 2024 Bulge In MDR Applications

Growing evidence demonstrates the one-year delay to the Medical Device Regulation, plus the expansion of the scope of products that could remain on the market beyond the MDR date of application, have simply pushed problems to 2024.

Do you like it?0

Named the #1 Regulatory Services Company 2022 by Life Sciences Review

X